NCT01851369
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +20 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Lymphomas
Explore clinical trials studying Lymphomas. Study availability and eligibility vary by location and protocol.
35 public trials
5 recruiting studies
Lymphomas trial results
NCT02140736
- Conditions
- Chemotherapy-induced Symptomatic Anemia, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Agen, France
- Aix-en-Provence, France
- Aix-en-Provence, France
- Aix-en-Provence, France
NCT03128164
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- TongJi Medical College Huazhong University of Science& Technology Wuhan, Hubei, China
- Sun Yat-sen University cancer center Guangzhou, China
- Fudan University Shanghai Cancer Center Shanghai, China
Completed
A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval
NCT01525394
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Charles River Tacoma, Washington, United States
NCT02169791
- Conditions
- Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
- Locations
-
- Northside Hospital Atlanta, Georgia, United States
NCT02740270
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Novartis Investigative Site Chicago, Illinois, United States
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site New York, United States
- Novartis Investigative Site Houston, Texas, United States
NCT01237236
- Conditions
- Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
- Memorial Sloan Kettering MSKCC (2) New York, United States
- Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States
Completed
tTF-NGR Phase I Study
NCT02902237
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University Hospital Muenster Münster, North Rhine-Westphalia, Germany
NCT01031641
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
NCT01273155
- Conditions
- Digestive System Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- University of California, Davis Davis, California, United States
- City of Hope National Medical Center Duarte, California, United States
- USC Norris Cancer Center Los Angeles, California, United States
- Emory University Atlanta, Georgia, United States